A citation-based method for searching scientific literature

Mar Cuadrado-Tejedor, Marta Pérez-González, Cristina García-Muñoz, Damián Muruzabal, Carolina García-Barroso, Obdulia Rabal, Víctor Segura, Juan A Sánchez-Arias, Julen Oyarzabal, Ana Garcia-Osta. Front Aging Neurosci 2019
Times Cited: 11







List of co-cited articles
47 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?
Claudia Simões-Pires, Vincent Zwick, Alessandra Nurisso, Esther Schenker, Pierre-Alain Carrupt, Muriel Cuendet. Mol Neurodegener 2013
159
36

Tubastatin A/ACY-1215 improves cognition in Alzheimer's disease transgenic mice.
Ling Zhang, Cui Liu, Jie Wu, Jing-Jing Tao, Xiao-Long Sui, Zhi-Gang Yao, Yan-Feng Xu, Lan Huang, Hua Zhu, Shu-Li Sheng,[...]. J Alzheimers Dis 2014
93
36

Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin,[...]. ACS Chem Neurosci 2019
18
36

Design, synthesis, biological evaluation and in vivo testing of dual phosphodiesterase 5 (PDE5) and histone deacetylase 6 (HDAC6)-selective inhibitors for the treatment of Alzheimer's disease.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin,[...]. Eur J Med Chem 2018
28
36

HDAC2 negatively regulates memory formation and synaptic plasticity.
Ji-Song Guan, Stephen J Haggarty, Emanuela Giacometti, Jan-Hermen Dannenberg, Nadine Joseph, Jun Gao, Thomas J F Nieland, Ying Zhou, Xinyu Wang, Ralph Mazitschek,[...]. Nature 2009
27

Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation.
Christopher G Vecsey, Joshua D Hawk, K Matthew Lattal, Joel M Stein, Sara A Fabian, Michelle A Attner, Sara M Cabrera, Conor B McDonough, Paul K Brindle, Ted Abel,[...]. J Neurosci 2007
561
27

An epigenetic blockade of cognitive functions in the neurodegenerating brain.
Johannes Gräff, Damien Rei, Ji-Song Guan, Wen-Yuan Wang, Jinsoo Seo, Krista M Hennig, Thomas J F Nieland, Daniel M Fass, Patricia F Kao, Martin Kahn,[...]. Nature 2012
497
27

Design, Synthesis, and Biological Evaluation of First-in-Class Dual Acting Histone Deacetylases (HDACs) and Phosphodiesterase 5 (PDE5) Inhibitors for the Treatment of Alzheimer's Disease.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin,[...]. J Med Chem 2016
52
27

Decreased levels of guanosine 3', 5'-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease.
Ana Ugarte, Francisco Gil-Bea, Carolina García-Barroso, Ángel Cedazo-Minguez, M Javier Ramírez, Rafael Franco, Ana García-Osta, Julen Oyarzabal, Mar Cuadrado-Tejedor. Neuropathol Appl Neurobiol 2015
55
27

A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice.
Mar Cuadrado-Tejedor, Carolina Garcia-Barroso, Juan A Sánchez-Arias, Obdulia Rabal, Marta Pérez-González, Sara Mederos, Ana Ugarte, Rafael Franco, Victor Segura, Gertrudis Perea,[...]. Neuropsychopharmacology 2017
51
27

Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease.
Hui-Ju Tseng, Mei-Hsiang Lin, Young-Ji Shiao, Ying-Chen Yang, Jung-Chun Chu, Chun-Yung Chen, Yi-Ying Chen, Tony Eight Lin, Chih-Jou Su, Shiow-Lin Pan,[...]. Eur J Med Chem 2020
8
37

Multitarget Approach for the Treatment of Alzheimer's Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles.
Obdulia Rabal, Juan A Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin,[...]. ACS Chem Neurosci 2019
14
27

Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitors.
Michelle M Claffey, Christopher J Helal, Patrick R Verhoest, Zhijun Kang, Kristina S Fors, Stanley Jung, Jiaying Zhong, Mark W Bundesmann, Xinjun Hou, Shenping Lui,[...]. J Med Chem 2012
41
18

A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease.
Elias M Schwam, Timothy Nicholas, Robert Chew, Clare B Billing, Wendy Davidson, Darlene Ambrose, Larry D Altstiel. Curr Alzheimer Res 2014
46
18

Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease.
M Cuadrado-Tejedor, C Garcia-Barroso, J Sanzhez-Arias, S Mederos, O Rabal, A Ugarte, R Franco, M Pascual-Lucas, V Segura, G Perea,[...]. Clin Epigenetics 2015
37
18

Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease.
Juan A Sánchez-Arias, Obdulia Rabal, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Ana Ugarte, Elena Sáez, Maria Espelosin, Susana Ursua, Tan Haizhong,[...]. ACS Chem Neurosci 2017
25
18

The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease.
Shuang-Shuang Yang, Rui Zhang, Gang Wang, Yong-Fang Zhang. Transl Neurodegener 2017
59
18

Expression of the cGMP-specific phosphodiesterases 2 and 9 in normal and Alzheimer's disease human brains.
Elisabet Reyes-Irisarri, Marjanne Markerink-Van Ittersum, Guadalupe Mengod, Jan de Vente. Eur J Neurosci 2007
79
18

PDE9A inhibition rescues amyloid beta-induced deficits in synaptic plasticity and cognition.
Katja S Kroker, Chantal Mathis, Anelise Marti, Jean-Christophe Cassel, Holger Rosenbrock, Cornelia Dorner-Ciossek. Neurobiol Aging 2014
45
18

Mercaptoacetamide-based class II HDAC inhibitor lowers Aβ levels and improves learning and memory in a mouse model of Alzheimer's disease.
You Me Sung, Taehee Lee, Hyejin Yoon, Amanda Marie DiBattista, Jung Min Song, Yoojin Sohn, Emily Isabella Moffat, R Scott Turner, Mira Jung, Jungsu Kim,[...]. Exp Neurol 2013
89
18

Insight into binding of phosphodiesterase-9A selective inhibitors by crystal structures and mutagenesis.
Huanchen Wang, Xuan Luo, Mengchun Ye, Jing Hou, Howard Robinson, Hengming Ke. J Med Chem 2010
15
18

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition.
Maj-Linda Selenica, Leif Benner, Steven B Housley, Barbara Manchec, Daniel C Lee, Kevin R Nash, Jay Kalin, Joel A Bergman, Alan Kozikowski, Marcia N Gordon,[...]. Alzheimers Res Ther 2014
77
18

Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD.
Carolina García-Barroso, Ana Ricobaraza, María Pascual-Lucas, Nora Unceta, Alberto J Rico, Maria Aranzazu Goicolea, Joan Sallés, José Luis Lanciego, Julen Oyarzabal, Rafael Franco,[...]. Neuropharmacology 2013
100
18


The role of histone acetylation in age-associated memory impairment and Alzheimer's disease.
Roman Manuel Stilling, André Fischer. Neurobiol Learn Mem 2011
88
18

Early postnatal behavioral, cellular, and molecular changes in models of Huntington disease are reversible by HDAC inhibition.
Florian A Siebzehnrübl, Kerstin A Raber, Yvonne K Urbach, Anja Schulze-Krebs, Fabio Canneva, Sandra Moceri, Johanna Habermeyer, Dalila Achoui, Bhavana Gupta, Dennis A Steindler,[...]. Proc Natl Acad Sci U S A 2018
28
18

Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's disease.
Nambirajan Govindarajan, Pooja Rao, Susanne Burkhardt, Farahnaz Sananbenesi, Oliver M Schlüter, Frank Bradke, Jianrong Lu, André Fischer. EMBO Mol Med 2013
183
18

Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model.
Lei Sun, Elphine Telles, Molly Karl, Fengdong Cheng, Noreen Luetteke, Eduardo M Sotomayor, Robert H Miller, Edward Seto. Life Sci Alliance 2018
19
18

HDAC6 α-tubulin deacetylase: a potential therapeutic target in neurodegenerative diseases.
Guoyi Li, Huiyi Jiang, Ming Chang, Hongrong Xie, Linsen Hu. J Neurol Sci 2011
99
18

Deregulation of HDAC1 by p25/Cdk5 in neurotoxicity.
Dohoon Kim, Christopher L Frank, Matthew M Dobbin, Rachel K Tsunemoto, Weihong Tu, Peter L Peng, Ji-Song Guan, Byung-Hoon Lee, Lily Y Moy, Paola Giusti,[...]. Neuron 2008
219
18

Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.
J S Steffan, L Bodai, J Pallos, M Poelman, A McCampbell, B L Apostol, A Kazantsev, E Schmidt, Y Z Zhu, M Greenwald,[...]. Nature 2001
894
18


The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
Elizabeth A Thomas, Giovanni Coppola, Paula A Desplats, Bin Tang, Elisabetta Soragni, Ryan Burnett, Fuying Gao, Kelsey M Fitzgerald, Jenna F Borok, David Herman,[...]. Proc Natl Acad Sci U S A 2008
207
18

Vasopressin-induction of the immediate early gene, NGFI-A, in cultured hippocampal glial cells.
R D Brinton, R Yamazaki, C M Gonzalez, K O'Neill, S S Schreiber. Brain Res Mol Brain Res 1998
17
18



Epigenetic Modifications in Alzheimer's Neuropathology and Therapeutics.
Michelle Esposito, Goldie Libby Sherr. Front Neurosci 2019
25
18

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.
M P Lambert, A K Barlow, B A Chromy, C Edwards, R Freed, M Liosatos, T E Morgan, I Rozovsky, B Trommer, K L Viola,[...]. Proc Natl Acad Sci U S A 1998
18

M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory.
Claude-Henry Volmar, Hasib Salah-Uddin, Karolina J Janczura, Paul Halley, Guerline Lambert, Andrew Wodrich, Sivan Manoah, Nidhi H Patel, Gregory C Sartor, Neil Mehta,[...]. Proc Natl Acad Sci U S A 2017
28
18

Alzheimer's disease.
Philip Scheltens, Kaj Blennow, Monique M B Breteler, Bart de Strooper, Giovanni B Frisoni, Stephen Salloway, Wiesje Maria Van der Flier. Lancet 2016
18

Phosphodiesterase inhibitors say NO to Alzheimer's disease.
Seyed Mohammad Nabavi, Sylwia Talarek, Joanna Listos, Seyed Fazel Nabavi, Kasi Pandima Devi, Marcos Roberto de Oliveira, Devesh Tewari, Sandro Argüelles, Saeed Mehrzadi, Azam Hosseinzadeh,[...]. Food Chem Toxicol 2019
20
18

Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression.
Raphael Hesse, Ludwig Lausser, Pauline Gummert, Florian Schmid, Anke Wahler, Cathrin Schnack, Katja S Kroker, Markus Otto, Hayrettin Tumani, Hans A Kestler,[...]. Alzheimers Res Ther 2017
12
18

HDAC6 regulates mitochondrial transport in hippocampal neurons.
Sigeng Chen, Geoffrey C Owens, Helen Makarenkova, David B Edelman. PLoS One 2010
171
18



Unusual zinc-binding mode of HDAC6-selective hydroxamate inhibitors.
Nicholas J Porter, Adaickapillai Mahendran, Ronald Breslow, David W Christianson. Proc Natl Acad Sci U S A 2017
76
18

Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally.
Yu Zhang, Sohee Kwon, Teppei Yamaguchi, Fabien Cubizolles, Sophie Rousseaux, Michaela Kneissel, Chun Cao, Na Li, Hwei-Ling Cheng, Katrin Chua,[...]. Mol Cell Biol 2008
377
18

Structural insights into HDAC6 tubulin deacetylation and its selective inhibition.
Yasuyuki Miyake, Jeremy J Keusch, Longlong Wang, Makoto Saito, Daniel Hess, Xiaoning Wang, Bruce J Melancon, Paul Helquist, Heinz Gut, Patrick Matthias. Nat Chem Biol 2016
141
9

Phosphodiesterase inhibition in cognitive decline.
Carolina García-Barroso, Ana Ugarte, Martín Martínez, Alberto J Rico, José Luis Lanciego, Rafael Franco, Julen Oyarzabal, Mar Cuadrado-Tejedor, Ana García-Osta. J Alzheimers Dis 2014
20
9

Phosphodiesterase type 3A regulates basal myocardial contractility through interacting with sarcoplasmic reticulum calcium ATPase type 2a signaling complexes in mouse heart.
Sanja Beca, Faiyaz Ahmad, Weixing Shen, Jie Liu, Samy Makary, Nazari Polidovitch, Junhui Sun, Steven Hockman, Youn Wook Chung, Matthew Movsesian,[...]. Circ Res 2013
86
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.